文献速递腹部技术与安全US

高帧率超声造影对≤3 cm小肝脏局灶性病变的诊断效能优于常规超声造影:一项多中心研究

Superior diagnostic performance of high frame rate Contrast-Enhanced ultrasound (HiFR-CEUS) for small focal liver lesions (≤3 cm): A multicenter study.
PubMed 文献 · Eur J Radiol · 2025-11-17

该回顾性多中心研究纳入150例肝脏局灶性病变患者,对比常规超声造影与高帧率超声造影的诊断效能。高帧率超声造影在≤3 cm病变组中显著改善边缘清晰度、增强方向与模式及血管结构的显示,诊断信心评分从3.7±0.8升至4.2±1.0(P<0.001),AUC从0.64升至0.87(P=0.0165)。

要点

  • ≤3 cm肝脏局灶性病变:高帧率超声造影AUC 0.87,常规超声造影AUC 0.64(P=0.0165)。
  • ≤3 cm组诊断信心评分:高帧率超声造影4.2±1.0 vs 常规超声造影3.7±0.8(P<0.001)。
  • ≤3 cm组高帧率超声造影显著改善边缘清晰度、增强方向与模式(P<0.001)及血管结构(P=0.001)的显示。

核心结论

  • 高帧率超声造影通过改善动态血管模式的显示,显著提升肝脏局灶性病变尤其是≤3 cm小病变的诊断能力,而常规超声造影在该尺寸病变中可能受限。

研究设计与样本

  • 回顾性多中心研究,纳入2022年5月至2024年5月经手术切除、粗针穿刺活检或影像学确诊的肝脏局灶性病变患者150例(平均年龄58.2岁,男性63.5%),其中恶性112例、良性38例;患者在同一次检查中先接受常规超声造影、后接受高帧率超声造影,两者均在病理诊断前一周内完成;采用5分法评估病变边缘及动脉期增强特征,按病变大小分为≤3 cm组、>3 cm且≤5 cm组和>5 cm组。

关键影像表现/征象

  • 在≤3 cm组中,高帧率超声造影较常规超声造影显著改善病变边缘清晰度的显示(P<0.001)。
  • 在≤3 cm组中,高帧率超声造影较常规超声造影显著改善增强方向与增强模式的显示(P<0.001)。
  • 在≤3 cm组中,高帧率超声造影较常规超声造影显著改善血管结构的显示(P=0.001)。

诊断标准与关键数值

  • 采用5分法评估病变边缘及动脉期增强特征,病变按大小分为≤3 cm组、>3 cm且≤5 cm组和>5 cm组。
  • ≤3 cm组中,高帧率超声造影诊断肝脏局灶性病变的AUC为0.87,常规超声造影AUC为0.64(P=0.0165)。

临床应用与阅片要点

  • 作者认为这些发现支持将高帧率超声造影整合入临床实践,尤其用于高危患者小 nodules 的早期准确定性。
  • 原文指出上述做法与近期WFUMB及CEUS LI-RADS指南的推荐一致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the diagnostic efficacy of high frame rate contrast enhanced ultrasound (HiFR-CEUS) for focal liver lesions (FLLs) of different sizes, particularly for lesions ≤ 3 cm.

MATERIALS AND METHODS: In this retrospective multicenter study, patients with FLLs confirmed by surgical resection, core needle biopsy or radiologically confirmed between May 2022 and May 2024 were enrolled. Patients underwent conventional CEUS followed by HiFR-CEUS within one week prior to pathological diagnosis. Lesion margins and arterial phase enhancement characterization were assessed using a 5-point scale. Lesions were categorized into three size-based groups: group 1 (≤ 3 cm), group 2 (> 3 cm to ≤ 5 cm), and group 3 (> 5 cm). Diagnostic performance metrics and inter-modality comparisons were conducted.

RESULTS: Among 150 patients (mean age 58.2 years; 63.5 % male), 112 lesions were malignant and 38 lesions were benign. HiFR-CEUS significantly improved the depiction of lesion margin clarity (P < 0.001), enhancement direction and pattern (P < 0.001), and vascular architecture (P = 0.001) compared to conventional CEUS in group 1. The diagnostic confidence score of HiFR-CEUS improved significantly in group 1 (4.2 ± 1.0 vs. 3.7 ± 0.8, P < 0.001). The diagnostic performance of HiFR-CEUS was superior to that of conventional CEUS in group 1, with the AUC increasing from 0.64 to 0.87 (P = 0.0165).

CONCLUSION: HiFR-CEUS significantly enhances the diagnostic capability for FLLs, especially for small lesions (≤ 3 cm) where conventional CEUS may be limited, by improving visualization of dynamic vascular patterns. These findings support the integration of HiFR-CEUS into clinical practice, particularly for the early and accurate characterization of small nodules in high-risk patients, as recommended in recent WFUMB and CEUS LI-RADS guidelines.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Qiu YJ, Lu XY, Huang YL, et al. Superior diagnostic performance of high frame rate Contrast-Enhanced ultrasound (HiFR-CEUS) for small focal liver lesions (≤3 cm): A multicenter study. Eur J Radiol. 2025. PMID: 41273922. doi:10.1016/j.ejrad.2025.112527

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。